Clinical trials
Active, not recruiting Non-alcoholic Fatty Liver Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2016 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Madrigal Pharmaceuticals, Inc. | 2 |
| Northwestern University | 2 |
| University of California, San Diego | 2 |
| Akero Therapeutics, Inc | 1 |
| Brigham and Women's Hospital | 1 |
| Emory University | 1 |
| GlaxoSmithKline | 1 |
| Indiana University | 1 |
| Inventiva Pharma | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 32 |
| Liver Cirrhosis | 7 |
| Diabetes Mellitus, Type 2 | 3 |
| Fatty Liver | 3 |
| Fibrosis | 3 |
| Obesity | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Disease | 2 |
| Liver Diseases | 2 |
| Weight Loss | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.